What are the alternative uses for Depakote (valproate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alternative Uses for Depakote (Valproate)

Depakote (valproate) is primarily used for epilepsy and bipolar disorder, but can also be used for migraine prevention, as an adjunctive treatment in schizophrenia, and for certain neurological conditions with behavioral symptoms.

Primary FDA-Approved Indications

  • Epilepsy: Valproate is effective against various seizure types, including:

    • Convulsive epilepsy as monotherapy 1
    • Partial onset seizures 1
    • Generalized tonic-clonic seizures 1
    • Particularly effective for idiopathic and symptomatic generalized epilepsies 2
  • Bipolar Disorder:

    • Acute treatment of bipolar mania 1
    • Maintenance treatment of bipolar disorder (should continue for at least 2 years after the last episode) 1
    • Can be used in combination with antipsychotics for better efficacy in bipolar disorder 1

Additional Evidence-Based Uses

  • Migraine Prevention:

    • Recommended for prevention of episodic migraine with a "weak for" recommendation 1
    • Can be particularly helpful in patients who have both migraine and mood disorders 2
  • Adjunctive Treatment in Schizophrenia:

    • Can be combined with antipsychotics for faster improvement in psychopathology 3
    • Most extensively studied anticonvulsant for schizophrenia treatment 3
  • Status Epilepticus:

    • Used in refractory status epilepticus at doses of 20-30 mg/kg at a rate of 40 mg/min 1
    • As effective as phenytoin for seizure cessation but with fewer adverse effects like hypotension 1
  • Special Populations:

    • Can be used in people with intellectual disability and epilepsy 1
    • May have advantages over phenytoin or phenobarbital due to lower risk of behavioral adverse effects 1

Important Considerations and Cautions

  • Women of Childbearing Age:

    • Should be avoided if possible during pregnancy due to teratogenicity 4
    • Associated with neural tube defects (1-3% risk) 2
    • May be linked to decreased verbal intelligence in offspring with in utero exposure 4
    • Possible increased risk of polycystic ovary syndrome 4, 2
  • Monitoring Requirements:

    • Requires clinical and laboratory monitoring 1
    • Liver function tests are important due to rare but serious hepatotoxicity 2
  • Common Side Effects:

    • Weight gain 4
    • Gastrointestinal symptoms 4
    • Sedation and tremor 4
    • Mild elevation of hepatic enzymes 4
  • Serious Adverse Effects:

    • Hepatotoxicity (rare in adults but higher risk in children under 2 years) 2
    • Platelet disorders 2
    • Pancreatitis 2
    • Hyperammonemic encephalopathy 2

Dosing Considerations

  • Available in different formulations including immediate and sustained-release 2
  • Sustained-release formulations can be given once or twice daily 2
  • Extensively metabolized by the liver 2
  • Has potential drug interactions through inhibition of metabolism of other drugs (including phenobarbital, lamotrigine) 2

Emerging Uses

  • Behavioral symptoms in various neuropsychiatric conditions 3
  • Agitation in dementia, borderline personality disorder, and disruptive adolescents 3

When considering Depakote for alternative uses, it's important to weigh the potential benefits against the risk of adverse effects, especially in women of childbearing potential where the risks of teratogenicity are significant 4, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Schizophrenia and valproate.

Psychopharmacology bulletin, 2003

Research

A review of valproate in psychiatric practice.

Expert opinion on drug metabolism & toxicology, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.